EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-7771
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies ; volume:6 ; number:1 ; day:7 ; month:12 ; year:2018 ; pages:1-10 ; date:12.2018
Biomarker Research ; 6, Heft 1 (7.12.2018), 1-10, 12.2018
- Creator
-
Tremblay-LeMay, Rosemarie
Rastgoo, Nasrin
Pourabdollah, Maryam
Chang, Hong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40364-018-0148-5
- URN
-
urn:nbn:de:101:1-2019012701455424731758
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tremblay-LeMay, Rosemarie
- Rastgoo, Nasrin
- Pourabdollah, Maryam
- Chang, Hong
- SpringerLink (Online service)
Other Objects (12)
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Breast imaging findings in haematological malignancies
Genes of multidrug resistance in haematological malignancies
Targeting hypoxia in solid and haematological malignancies
Asbestos exposure and haematological malignancies: a Danish cohort study
The Application of CAR-T Cells in Haematological Malignancies
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Severe bleeding events among critically ill patients with haematological malignancies
ADP dependent glucokinase as a novel onco-target for haematological malignancies.
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review
EZH2: novel therapeutic target for human cancer
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Breast imaging findings in haematological malignancies
Genes of multidrug resistance in haematological malignancies
Targeting hypoxia in solid and haematological malignancies
Asbestos exposure and haematological malignancies: a Danish cohort study
The Application of CAR-T Cells in Haematological Malignancies
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Severe bleeding events among critically ill patients with haematological malignancies
ADP dependent glucokinase as a novel onco-target for haematological malignancies.
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review
EZH2: novel therapeutic target for human cancer
EZH2 abnormalities in lymphoid malignancies: underlying mechanisms and therapeutic implications
Breast imaging findings in haematological malignancies
Genes of multidrug resistance in haematological malignancies
Targeting hypoxia in solid and haematological malignancies
Asbestos exposure and haematological malignancies: a Danish cohort study
The Application of CAR-T Cells in Haematological Malignancies
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches
Attitudes towards COVID-19 Vaccination in Adults with Haematological Malignancies
Severe bleeding events among critically ill patients with haematological malignancies
ADP dependent glucokinase as a novel onco-target for haematological malignancies.
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review